Gamma Communications, a UK-based telecoms services provider, has postponed a shareholder vote on a takeover backed by private equity firm Epiris. The meeting, originally scheduled for an earlier date, will now take place on November 2. The delay comes after early proxy votes were cast by holders of less than 40% of the company's eligible shares.
In a statement, Gamma said the low early turnout reflects the current composition of its shareholder base. The company estimates that merger-arbitrage funds—investors who buy shares specifically to profit from the expected completion of a deal—control roughly 50% of its economic interests. These funds often wait until the last moment to cast their votes, as they continuously reassess the likelihood that the acquisition will close versus the potential payout if it does.
What is a proxy vote and why does turnout matter?
A proxy vote is a ballot cast by a shareholder who cannot attend a company meeting in person, authorising someone else—usually management or a designated representative—to vote on their behalf. In a takeover situation, the acquiring party typically needs approval from a majority of shareholders who actually vote, and sometimes a threshold of total eligible shares. Low turnout can jeopardise the vote's validity or signal a lack of support, prompting companies to delay to give more time for votes to come in.
Gamma's decision to push the meeting to November 2 is a practical move to avoid a failed or contested vote. By waiting, the company hopes that more shareholders—particularly the arbitrage funds—will submit their ballots, allowing the deal to proceed with a clearer mandate.
Why merger-arbitrage funds vote late
Merger arbitrage is a strategy where investors buy shares of a target company after a takeover is announced, betting that the deal will complete at the offered price. The profit comes from the gap between the current market price and the acquisition price. These funds are highly attuned to deal risk: if the acquisition falls through, the share price typically drops, and they lose money. As a result, they constantly update their positions based on news, regulatory hurdles, and other developments.
Because their voting decisions are tied to their ongoing assessment of the deal's chances, arbitrage funds often delay voting until the last possible moment. They may also change their instructions if new information emerges. This behaviour is well known in the M&A world, and companies frequently extend deadlines to accommodate it.
Gamma's situation is not unique. Other recent takeover votes have faced similar dynamics. For example, a rival bidder's absence helped clear the path for another UK deal, while a court ruling forced a buyer to complete a takeover after a dispute. These cases highlight how shareholder voting and legal processes can shape the outcome of M&A transactions.
What this means for investors
For everyday investors holding Gamma shares, the delay is a sign that the deal is not yet a done deal. The outcome now hinges on whether enough shareholders—especially the arbitrage funds—turn out to vote by November 2. If the vote passes, shareholders will receive the takeover consideration, which is typically a cash payment or a mix of cash and shares. If it fails, the share price could fall, as the market would likely price in a lower probability of the deal completing.
Investors should also be aware that merger-arbitrage funds are sophisticated players who may have different objectives than long-term shareholders. Their willingness to vote yes is tied to the deal's economics, not to the company's long-term prospects. This means that even if the vote passes, it may not reflect the views of all shareholders.
For those watching the broader M&A landscape, Gamma's delay is a reminder that takeovers are not always smooth. Regulatory approvals, shareholder votes, and financing conditions can all cause hiccups. Other deals, like the recent FleetPartners acquisition, have proceeded without such delays, but each transaction has its own set of risks.
Gamma's next key date is November 2, when shareholders will finally have their say. Until then, the market will be watching for any signs of how the vote is trending. If the arbitrage funds decide to support the deal, it is likely to pass. If they hold back, the company may face a longer road to completion.
In the meantime, investors should keep an eye on any updates from Gamma or Epiris, as well as any regulatory announcements that could affect the deal's timeline. As with any M&A situation, the price of Gamma's shares will continue to reflect the market's view of the deal's probability.
